The Georgetown University researchers, concerned about the number of complications after taking medicines for Alzheimer's disease, are back to experiments on laboratory mice. During the experiments, they were able to find out what the problem was in the swelling of the brain as a result of the aggressive reaction of the body to the drug.
Also, scientists have found that administration of the drug with beta-amyloid in the late stage of Alzheimer's triggers an immune response, which can be avoided if the drug administered to generate antibodies as early as possible when amyloid deposits are still small.
Observations of the experimental mice showed that the earlier start to use of the drug (in the early stages of the disease), the easier reaction to a medicine, and the faster the visible improvements occur.
Studies have indicated, first, the need for more careful monitoring of the brain in patients taking drugs for Alzheimer's disease, and secondly, gave rise to more intensive treatment in the early stages of the disease in those cases when it was possible to identify excess amyloid during.
|
|
|
|
Other news
Go back to the main page
No comments:
Post a Comment